147 related articles for article (PubMed ID: 16926597)
1. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
[TBL] [Abstract][Full Text] [Related]
2. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Fiehn C; Müller-Ladner U; Gay S; Krienke S; Freudenberg-Konrad S; Funk J; Ho AD; Sinn H; Wunder A
Rheumatology (Oxford); 2004 Sep; 43(9):1097-105. PubMed ID: 15199219
[TBL] [Abstract][Full Text] [Related]
3. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
4. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapy.
Hickstein H; Wolff D; Stange J; Frei E; Hartung G
Transplant Proc; 2008 Dec; 40(10):3725-7. PubMed ID: 19100475
[TBL] [Abstract][Full Text] [Related]
6. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.
Fiehn C; Neumann E; Wunder A; Krienke S; Gay S; Müller-Ladner U
Ann Rheum Dis; 2004 Jul; 63(7):884-6. PubMed ID: 15194591
[TBL] [Abstract][Full Text] [Related]
8. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Narimatsu H; Terakura S; Matsuo K; Oba T; Uchida T; Iida H; Hamaguchi M; Watanabe M; Kohno A; Murata M; Sawa M; Miyamura K; Morishita Y
Bone Marrow Transplant; 2007 Jan; 39(1):31-9. PubMed ID: 17115066
[TBL] [Abstract][Full Text] [Related]
9. Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.
Inagaki J; Nagatoshi Y; Hatano M; Isomura N; Sakiyama M; Okamura J
Bone Marrow Transplant; 2008 Mar; 41(6):571-7. PubMed ID: 18026150
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation.
Yu C; Seidel K; Fitzsimmons WE; Sale G; Storb R
Bone Marrow Transplant; 1997 Jul; 20(2):137-41. PubMed ID: 9244417
[TBL] [Abstract][Full Text] [Related]
11. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and toxicity of 10-ethyl-10-deazaaminopterin and methotrexate in a mycobacterial rat arthritis model.
Skeith KJ; Ramos-Remus C; Russell AS
J Rheumatol; 1994 Mar; 21(3):473-5. PubMed ID: 8006891
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
Hoyt R; Ritchie DS; Roberts AW; Macgregor L; Curtis DJ; Szer J; Grigg AP
Bone Marrow Transplant; 2008 Apr; 41(7):651-8. PubMed ID: 18176619
[TBL] [Abstract][Full Text] [Related]
15. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
18. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
Bostík J; Bures L; Spundová M
Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats.
Xue F; Chen W; Wang XG; Liang L; Bai XL; Wang LY; Wang HP; Liang TB
Transplant Proc; 2009 Jun; 41(5):1914-20. PubMed ID: 19545756
[TBL] [Abstract][Full Text] [Related]
20. First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
Wang Y; Xu LP; Liu DH; Chen H; Chen YH; Han W; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2009 Apr; 15(4):505-11. PubMed ID: 19285639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]